All tenders
75N98026P01298
ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS VERSUS DPP-4 INHIBITORS FOR ALCOHOL AND SUBSTANCE USE DISORDERS IN IMPROVING HIV-RELATED OUTCOMES AND PROVIDING HEALTH BENEFITS IN PEOPLE LIVING WITH HIV
Department of Health and Human Services · CT, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N98026P01298
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS VERSUS DPP-4 INHIBITORS FOR ALCOHOL AND SUBSTANCE USE DISORDERS IN IMPROVING HIV-RELATED OUTCOMES AND PROVIDING HEALTH BENEFITS IN PEOPLE LIVING WITH HIV
- Source
- usaspending
- Source ID
- CONT_AWD_75N98026P01298_7529_-NONE-_-NONE-
Details
- Location
- CT, United States
Description
ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS VERSUS DPP-4 INHIBITORS FOR ALCOHOL AND SUBSTANCE USE DISORDERS IN IMPROVING HIV-RELATED OUTCOMES AND PROVIDING HEALTH BENEFITS IN PEOPLE LIVING WITH HIV Awarded to: YALE UNIV Sub-agency: National Institutes of Health Contract type: PURCHASE ORDER
Dates
- Publication
- 2026/08/24 12:00:00 AM UTC
- Closing date
- 2027/08/23 12:00:00 AM UTC
Estimated value
$252K USD
Classification
Normalized category
Healthcare & Medical